Jeffrey Dierks - 07 Sep 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: Chief Commercial Officer
Signature: /s/ Christian Ulrich, Attorney-in-fact for Jeffrey Dierks
Issuer symbol: HRMY
Transactions as of: 07 Sep 2021
Net transactions value: -$143,900
Form type: 4
Filing time: 09 Sep 2021, 21:34:50 UTC
Previous filing: 03 Sep 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$41,100	+5,000		$8.22^*	5,000	07 Sep 2021	Direct
transaction	HRMY	Common Stock	Sale	$185,000	-5,000	-100%	$37.00	0	07 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Options Exercise	$0	-4,083	-36%	$0.000000	7,304	07 Sep 2021	Common Stock	4,083	$8.22	Direct	F2, F4
transaction	HRMY	Stock Option	Options Exercise	$0	-917	-3.8%	$0.000000	23,428	07 Sep 2021	Common Stock	917	$8.22	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The stock option is currently vested with respect to 4,868 shares, and will vest with respect to the remainder of the shares in three equal annual installments beginning on October 1, 2021.
F3	The stock option is currently vested with respect to 4,869 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022.
F4	Reflects the exercise of 785 stock options on September 1, 2021, which was reported on the Form 4 filed by the reporting person on September 3, 2021, but erroneously reflected as an exercise of the tranche which expires on October 2, 2027, rather than the tranche which expires on October 1, 2028.